Arcadia Biosciences, Inc. (RKDA) › Capital ExpendituresArcadia Biosciences, Inc. (RKDA) — Capital ExpendituresAnnual figures by period end, from SEC filings.2014-12-31: $148.0K2015-12-31: $151.0K2016-12-31: $231.0K2017-12-31: $79.0K2018-12-31: $250.0K2019-12-31: $1.48M2020-12-31: $2.33M2021-12-31: $1.01M2022-12-31: $72.0K2023-12-31: $5.0K2024-12-31: $16.0K2025-12-31: $0$02014-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$0-100.0%2026-03-26From 2025-01-012024-12-31$16.0K+220.0%2026-03-26From 2024-01-012023-12-31$5.0K-93.1%2025-03-25From 2023-01-012022-12-31$72.0K-92.9%2024-03-28From 2022-01-012021-12-31$1.01M-56.9%2023-03-30From 2021-01-012020-12-31$2.33M+58.1%2022-03-31From 2020-01-012019-12-31$1.48M+490.8%2021-03-31From 2019-01-012018-12-31$250.0K+216.5%2020-03-25From 2018-01-012017-12-31$79.0K-65.8%2019-04-01From 2017-01-012016-12-31$231.0K+53.0%2018-03-20From 2016-01-012015-12-31$151.0K+2.0%2017-03-08From 2015-01-012014-12-31$148.0K—2016-03-08From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)